Effect of Obesity on Response to Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction

Obesity is common in heart failure with preserved ejection fraction (HFpEF). Whether obesity modifies the response to spironolactone in patients with HFpEF remains unclear. We aimed to investigate the effect of obesity, defined by body mass index (BMI) and waist circumference (WC), on response to sp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Cardiol
Hlavní autoři: Elkholey, Khaled, Papadimitriou, Lampros, Butler, Javed, Thadani, Udho, Stavrakis, Stavros
Médium: Artigo
Jazyk:Inglês
Vydáno: 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8038969/
https://ncbi.nlm.nih.gov/pubmed/33529620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2021.01.018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky